Company Filing History:
Years Active: 2007
Title: Masayuki Shirakura: Innovator in Gene Therapy
Introduction
Masayuki Shirakura is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of gene therapy, particularly through his innovative work with viral vectors. His research focuses on the efficient transfer of nucleic acids into nerve cells, which has important implications for medical treatments.
Latest Patents
Shirakura holds a patent for "Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci." This invention utilizes a negative-sense RNA virus vector to facilitate the transfer of nucleic acid into nerve cells. The method developed by Shirakura can be effectively used for introducing genes into nerve cells, including central nerve tissue, which is crucial for advancements in gene therapy.
Career Highlights
Masayuki Shirakura is associated with Dna Vec Research Inc., where he continues to push the boundaries of genetic research. His work has garnered attention for its potential applications in treating neurological disorders and enhancing gene therapy techniques.
Collaborations
Shirakura has collaborated with notable colleagues, including Masayuki Fukumura and Makoto Asakawa. These partnerships have contributed to the advancement of research in the field of gene therapy.
Conclusion
Masayuki Shirakura's innovative work in gene therapy exemplifies the potential of viral vectors in medical science. His contributions are paving the way for new treatments and therapies that could significantly impact patient care.